The Social Security Administration Expedites Some Claims for Disability Benefits, But Not Advanced Prostate Cancer
Social Security Announces Nationwide Launch of Compassionate Allowances Process Will Fast Track Applications For People with Cancers and Rare Diseases Michael J. Astrue, Commissioner of Social Security, today announced the national rollout of the agency’s [...]
Jumbo Jet Crashes Killing All – So What
Imagine these headlines in your local newspaper: JUMBO JET CRASHES KILLING ALL – 1,000 PEOPLE DIE! The front pages of all of our newspapers would scream about this massive tragedy of “epic proportions.” Now imagine [...]
The FDA Launches a Web Site that Allows Us to Access Complete Drug Information
The FDA has launched a web site that is now available to both patients and health care professionals that gives complete access to the information on file about all adverse effects and drug safety concerns [...]
Early Versus Deferred Androgen Suppression in the Treatment of Advanced Prostatic Cancer – Which Is Better?
An informative and comprehensive analysis of existing research studies evaluating the merits of early vs. deferred commencement of hormone therapy in men with advanced prostate cancer was recently published. The analysis (Wilt T, Nair B, [...]
Prominent Attorney with Terminal Cancer Gets Tysabri After Biogen Idec’s Earlier Denial- Its Implications for Prostate Cancer Treatment
A prominent attorney, Frederick Baron, who is dying of bone marrow cancer, has been granted his wish, to receive the drug Tysabri. After significant wrangling, The FDA and the Mayo Clinic found a legal basis [...]
Interim Phase II Results Support A Positive result Of CB7630 (Abiraterone Acetate) In Advanced Prostate Cancer Patients
Today, Cougar Biotechnology, Inc. (NASDAQ:CGRB) unveiled the results from its ongoing Phase II clinical trial drug CB7630 (abiraterone acetate). The data was presented at the Prostate Cancer Foundation Scientific Retreat in Lake Tahoe, Nevada. The [...]